Figure 7.
Assessment of PLN levels in LV and RV. (A) Representative immunoblots of PLN and SERCA2a protein levels in LV from WT-PLN and R14del-PLN. (B) Quantitative assessment of PLN protein levels in LV. (C) Quantitative assessment of SERCA2a protein levels in LV. Calsequestrin (CSQ) was used as a loading control. N = 6 LV samples from WT and N = 6 LV samples from R14del-PLN mice. (D) Representative immunoblots of PLN and SERCA2a protein levels in RV from WT-PLN and R14del-PLN. (E) Quantitative assessment of PLN protein levels in RV. (F) Quantitative assessment of SERCA2a protein levels in RV. Calsequestrin (CSQ) was used as a loading control. N = 6 RV samples from WT and N = 6 RV samples from R14del-PLN mice. (G,H) The PLN/SERCA2a ratio in RV and LV samples. Twelve- to fourteen-week-old male mice were used. Data are expressed as mean ± SEM for the number of hearts and statistical analyses were performed by two-tailed unpaired t-test. A p-value of <0.05 was considered statistically significant.